FDA inspection
Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site): FDA inspection ending Jan 14, 2025
FDA inspection 1259422 · Voluntary Action Indicated (VAI) · Jinan
Key facts
| Inspection ID | 1259422 |
|---|---|
| Firm | Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) |
| FEI number | 3003802432 |
| Address | 317 Xinluo Road, High Tech Zone |
| City | Jinan |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Jan 14, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data